Literature DB >> 32269979

Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?

Stephen E Langabeer1.   

Abstract

Entities:  

Year:  2020        PMID: 32269979      PMCID: PMC7106119          DOI: 10.5045/br.2020.55.1.67

Source DB:  PubMed          Journal:  Blood Res        ISSN: 2287-979X


× No keyword cloud information.
  6 in total

1.  Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms.

Authors:  M I Stefanou; H Richter; F Härtig; Y Wang; A Örgel; B Bender; A Mengel; U Ziemann; S Poli
Journal:  Eur J Neurol       Date:  2019-02-08       Impact factor: 6.089

Review 2.  Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors.

Authors:  Minas P Economides; Srdan Verstovsek; Naveen Pemmaraju
Journal:  Curr Hematol Malig Rep       Date:  2019-10       Impact factor: 3.952

3.  Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders.

Authors:  Daniela Pietra; Sai Li; Angela Brisci; Francesco Passamonti; Elisa Rumi; Alexandre Theocharides; Maurizio Ferrari; Heinz Gisslinger; Robert Kralovics; Laura Cremonesi; Radek Skoda; Mario Cazzola
Journal:  Blood       Date:  2007-11-05       Impact factor: 22.113

4.  Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.

Authors:  Valery L Feigin; Grant Nguyen; Kelly Cercy; Catherine O Johnson; Tahiya Alam; Priyakumari G Parmar; Amanuel A Abajobir; Kalkidan H Abate; Foad Abd-Allah; Ayenew N Abejie; Gebre Y Abyu; Zanfina Ademi; Gina Agarwal; Muktar B Ahmed; Rufus O Akinyemi; Rajaa Al-Raddadi; Leopold N Aminde; Catherine Amlie-Lefond; Hossein Ansari; Hamid Asayesh; Solomon W Asgedom; Tesfay M Atey; Henok T Ayele; Maciej Banach; Amitava Banerjee; Aleksandra Barac; Suzanne L Barker-Collo; Till Bärnighausen; Lars Barregard; Sanjay Basu; Neeraj Bedi; Masoud Behzadifar; Yannick Béjot; Derrick A Bennett; Isabela M Bensenor; Derbew F Berhe; Dube J Boneya; Michael Brainin; Ismael R Campos-Nonato; Valeria Caso; Carlos A Castañeda-Orjuela; Jacquelin C Rivas; Ferrán Catalá-López; Hanne Christensen; Michael H Criqui; Albertino Damasceno; Lalit Dandona; Rakhi Dandona; Kairat Davletov; Barbora de Courten; Gabrielle deVeber; Klara Dokova; Dumessa Edessa; Matthias Endres; Emerito J A Faraon; Maryam S Farvid; Florian Fischer; Kyle Foreman; Mohammad H Forouzanfar; Seana L Gall; Tsegaye T Gebrehiwot; Johanna M Geleijnse; Richard F Gillum; Maurice Giroud; Alessandra C Goulart; Rahul Gupta; Rajeev Gupta; Vladimir Hachinski; Randah R Hamadeh; Graeme J Hankey; Habtamu A Hareri; Rasmus Havmoeller; Simon I Hay; Mohamed I Hegazy; Desalegn T Hibstu; Spencer L James; Panniyammakal Jeemon; Denny John; Jost B Jonas; Jacek Jóźwiak; Rizwan Kalani; Amit Kandel; Amir Kasaeian; Andre P Kengne; Yousef S Khader; Abdur R Khan; Young-Ho Khang; Jagdish Khubchandani; Daniel Kim; Yun J Kim; Mika Kivimaki; Yoshihiro Kokubo; Dhaval Kolte; Jacek A Kopec; Soewarta Kosen; Michael Kravchenko; Rita Krishnamurthi; G Anil Kumar; Alessandra Lafranconi; Pablo M Lavados; Yirga Legesse; Yongmei Li; Xiaofeng Liang; Warren D Lo; Stefan Lorkowski; Paulo A Lotufo; Clement T Loy; Mark T Mackay; Hassan Magdy Abd El Razek; Mahdi Mahdavi; Azeem Majeed; Reza Malekzadeh; Deborah C Malta; Abdullah A Mamun; Lorenzo G Mantovani; Sheila C O Martins; Kedar K Mate; Mohsen Mazidi; Suresh Mehata; Toni Meier; Yohannes A Melaku; Walter Mendoza; George A Mensah; Atte Meretoja; Haftay B Mezgebe; Tomasz Miazgowski; Ted R Miller; Norlinah M Ibrahim; Shafiu Mohammed; Ali H Mokdad; Mahmood Moosazadeh; Andrew E Moran; Kamarul I Musa; Ruxandra I Negoi; Minh Nguyen; Quyen L Nguyen; Trang H Nguyen; Tung T Tran; Thanh T Nguyen; Dina Nur Anggraini Ningrum; Bo Norrving; Jean J Noubiap; Martin J O’Donnell; Andrew T Olagunju; Oyere K Onuma; Mayowa O Owolabi; Mahboubeh Parsaeian; George C Patton; Michael Piradov; Martin A Pletcher; Farshad Pourmalek; V Prakash; Mostafa Qorbani; Mahfuzar Rahman; Muhammad A Rahman; Rajesh K Rai; Annemarei Ranta; David Rawaf; Salman Rawaf; Andre MN Renzaho; Stephen R Robinson; Ramesh Sahathevan; Amirhossein Sahebkar; Joshua A Salomon; Paola Santalucia; Itamar S Santos; Benn Sartorius; Aletta E Schutte; Sadaf G Sepanlou; Azadeh Shafieesabet; Masood A Shaikh; Morteza Shamsizadeh; Kevin N Sheth; Mekonnen Sisay; Min-Jeong Shin; Ivy Shiue; Diego A S Silva; Eugene Sobngwi; Michael Soljak; Reed J D Sorensen; Luciano A Sposato; Saverio Stranges; Rizwan A Suliankatchi; Rafael Tabarés-Seisdedos; David Tanne; Cuong Tat Nguyen; J S Thakur; Amanda G Thrift; David L Tirschwell; Roman Topor-Madry; Bach X Tran; Luong T Nguyen; Thomas Truelsen; Nikolaos Tsilimparis; Stefanos Tyrovolas; Kingsley N Ukwaja; Olalekan A Uthman; Yuri Varakin; Tommi Vasankari; Narayanaswamy Venketasubramanian; Vasiliy V Vlassov; Wenzhi Wang; Andrea Werdecker; Charles D A Wolfe; Gelin Xu; Yuichiro Yano; Naohiro Yonemoto; Chuanhua Yu; Zoubida Zaidi; Maysaa El Sayed Zaki; Maigeng Zhou; Boback Ziaeian; Ben Zipkin; Theo Vos; Mohsen Naghavi; Christopher J L Murray; Gregory A Roth
Journal:  N Engl J Med       Date:  2018-12-20       Impact factor: 91.245

5.  Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria.

Authors:  Ik-Chan Song; Yoon-Seok Choi; Jong Wook Shin; Hee-Jung Song; Jei Kim; Deog-Yeon Jo
Journal:  Blood Res       Date:  2019-12-20

6.  MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.

Authors:  Philip A Beer; Peter J Campbell; Linda M Scott; Anthony J Bench; Wendy N Erber; David Bareford; Bridget S Wilkins; John T Reilly; Hans C Hasselbalch; Richard Bowman; Keith Wheatley; Georgina Buck; Claire N Harrison; Anthony R Green
Journal:  Blood       Date:  2008-05-01       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.